Concepedia

Author

N.C.L McNaughton

GlaxoSmithKline (United Kingdom)

Also Known As

N. C. L. McNaughton, N.C.L McNaughton, N.C.L. McNaughton, Nicolle C.L McNaughton, Nicolle C.L. McNaughton

13

Publications

322

Citations

10

H-Index

27

Concepts

All Affiliations

GlaxoSmithKline (United Kingdom)MRC Laboratory of Molecular BiologyDe Montfort University
NM

About

N.C.L McNaughton is an author at GlaxoSmithKline (United Kingdom) specializing in social sciences, neurophysiology, and neuroscience.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

7

7

189

2

Social Sciences

7

7

189

3

Cellular Physiology

3

3

112

4

Neurology

2

2

35

5

Cell Biology

1

1

40

N.C.L McNaughton

×

10

Publications

312

Citations

10

H-Index

YearCitations

Actions of sipatrigine, 202W92 and lamotrigine on R-type and T-type Ca2+ channel currents

Atticus H. Hainsworth, N.C.L McNaughton, Alexey Pereverzev,

European Journal of Pharmacology

2003

72

Electrophysiological properties of the human N-type Ca2+ channel: I. Channel gating in Ca2+, Ba2+ and Sr2+ containing solutions

N.C.L McNaughton, Andrew D. Randall

Neuropharmacology

1997

47

Kinetic modification of the α<sub>1I</sub> subunit‐mediated T‐type Ca<sup>2+</sup> channel by a human neuronal Ca<sup>2+</sup> channel γ subunit

P. J. Green, Ruth Warre, Philip D. Hayes,

The Journal of Physiology

2001

40

Inhibition of α1E Ca2+ Channels by Carbonic Anhydrase Inhibitors

N.C.L McNaughton, Ceri H. Davies, Andrew D. Randall

Journal of Pharmacological Sciences

2004

37

Electrophysiological characterisation of the human N-type Ca2+ channel II

N.C.L McNaughton, David Bleakman, Andrew D. Randall

Neuropharmacology

1998

26

Inhibition of recombinant low-voltage-activated Ca2+ channels by the neuroprotective agent BW619C89 (Sipatrigine)

N.C.L McNaughton, Atticus H. Hainsworth, P.J Green,

Neuropharmacology

2000

25

Neuroprotective actions in vivo and electrophysiological actions in vitro of 202W92

Luigi Caputi, Atticus H. Hainsworth, Franco Lavaroni,

Brain Research

2001

21

Inhibition of human N-type voltage-gated Ca2+ channels by the neuroprotective agent BW619C89

N.C.L McNaughton, M.J. Leach, Atticus H. Hainsworth,

Neuropharmacology

1997

16

Inhibition of human α<sub>1E</sub> subunit‐mediated Ca<sup>2+</sup> channels by the antipsychotic agent chlorpromazine

N.C.L McNaughton, P. J. Green, Andrew D. Randall

Acta Physiologica Scandinavica

2001

14

Inhibition of Ih reduces epileptiform activity in rodent hippocampal slices

Catherine H. Gill, Jon T. Brown, Nadia Shivji,

Synapse

2006

14

Page 1